Comparison of outcomes for continuous laboratory variables at week 48 between treatment groups.</p
Comparisons of means and relative frequencies across outcome variables in the matched groups.</p
Results comparing Assessment #1 and Assessment #3 representing combined effects of both treatments.<...
<p>Comparison of bacterial group median quantities at each timepoint within treatment arms.</p
Comparisons of clinical outcome between the severe group and the moderate group.</p
Comparison of primary outcome variables for base line and end line in control and intervention group...
Comparison of quality of life between experimental groups before and after the proposed treatment.</...
Comparison of secondary outcomes variables for base line and end line in control and intervention gr...
<p>Results from different groups according to the duration of medication administration.</p
<p>Comparison of the primary outcome, treatment failure at 1 week, between treatment arms.</p
Comparison of laboratory tests costs in ICU A according to different periods.</p
Comparison of results before the introduction of DTG/DRV/r therapy and at 48 weeks of treatment.</p
Laboratory parameters compared between active and stable episodes for 63 patients.</p
<p>Comparison of selected demographic and clinical variables between the groups.</p
<p>Comparison of general conditions and clinical manifestations between the groups.</p
Comparison of laboratory parameters of SFTS patients in the HPE and AP groups.</p
Comparisons of means and relative frequencies across outcome variables in the matched groups.</p
Results comparing Assessment #1 and Assessment #3 representing combined effects of both treatments.<...
<p>Comparison of bacterial group median quantities at each timepoint within treatment arms.</p
Comparisons of clinical outcome between the severe group and the moderate group.</p
Comparison of primary outcome variables for base line and end line in control and intervention group...
Comparison of quality of life between experimental groups before and after the proposed treatment.</...
Comparison of secondary outcomes variables for base line and end line in control and intervention gr...
<p>Results from different groups according to the duration of medication administration.</p
<p>Comparison of the primary outcome, treatment failure at 1 week, between treatment arms.</p
Comparison of laboratory tests costs in ICU A according to different periods.</p
Comparison of results before the introduction of DTG/DRV/r therapy and at 48 weeks of treatment.</p
Laboratory parameters compared between active and stable episodes for 63 patients.</p
<p>Comparison of selected demographic and clinical variables between the groups.</p
<p>Comparison of general conditions and clinical manifestations between the groups.</p
Comparison of laboratory parameters of SFTS patients in the HPE and AP groups.</p
Comparisons of means and relative frequencies across outcome variables in the matched groups.</p
Results comparing Assessment #1 and Assessment #3 representing combined effects of both treatments.<...
<p>Comparison of bacterial group median quantities at each timepoint within treatment arms.</p
DOI
Add to ORKG